:: Advanced Search
Site Search
Search other sites
MCQs
Speaker Profile | Presentation | Handout | MCQ | Back to Symposiums
MCQs on "Update in Management of Immune Thrombocytopenia" by Dr. Chen Yi Tin
Direction: Choose the single best answer and give a tick in the corresponding box on the answer form.

1.

33-year-old female complains of a rash on her ankles and shins and easy bruising for 10 days. The rash is not itchy or painful. She denies recent contact with new soaps or detergents. The bruises occur on her arms and sides unrelated to trauma.

On further questioning she reports nosebleeds, gum bleeding with flossing and an unusually heavy menses one week ago. She had an upper respiratory infection 3 weeks ago, which has now resolved. On physical exam she has no lymphadenopathy or hepatosplenomegaly.

Her signs and symptoms are most suggestive of what type of bleeding disorder? Select the most likely choice.

 a) Interruption of vascular integrity
 b) Coagulation abnormality
 c) Abnormality of primary hemostasis

2.Which of the following drugs may be implicated in thrombocytopenia:
 a) phenytoin
 b) rifampicin
 c) Quinine
 d) NSAID
 e) All of the above

3.Which of the following should not be used in young female patients with refractory autoimmune thrombocytopenia?
 a) Rituximab
 b) Danazol
 c) Eltrombopag
 d) Cyclosporin
 e) Splenectomy

4.Which of the following about Anti-RhD immunoglobulin in the treatment of very severe immune thrombocytopenia is not true:
 a) May be used in Rh-negative patients.
 b) Should not be used in post-splenectomized patients
 c) May cause hemolytic anemia
 d) Lower cost than IVIG(intravenous immunoglobulin)
 e) Around 70% of patients respond

5.Which of the following should be considered in the initial differential diagnosis of thrombocytopenia?
 a) Hepatitis C infection
 b) Helicobacter pylori infection
 c) Alcholisim
 d) HIV infection
 e) All of the above

Answers for this quiz are not yet available.

 

 


 

 
©2005 Hong Kong Doctors Union. All rights reserved. | Powered by Medcom Ltd.